5.19.2017
Talk to your doctor about Glut1 Deficiency Syndrome Many neurologic conditions share the symptoms of Glucose Transporter Type 1 deficiency… Continue Reading
5.18.2017
Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for… Continue Reading
Catalyst Pharmaceuticals Receives 2017 Beacon Council Award for Contributions in Life Sciences & Healthcare
5.18.2017
Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for… Continue Reading
National Leiomyosarcoma Foundation and Rare Cancer Research Foundation Team Up to Study Tumor Tissue
5.16.2017
The National Leiomyosarcoma Foundation announces an exciting new collaborative partnership with the Rare Cancer Research Foundation (RCRF),… Continue Reading
5.15.2017
Cell therapy company jCyte announced that the U.S. Food & Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy… Continue Reading
Abeona Therapeutics Receives Regulatory Approval to Initiate Clinical Trial in Australia with ABO-102 Gene Therapy For Patients with MPS IIIA
5.14.2017
Clinical Trial Notification (CTN) Enables Initiation at 3rd Global Site and Accelerates Enrollment in the ABO-102 MPS IIIA Gene Therapy… Continue Reading
5.13.2017
SideEQ is a free, interactive platform which enables people living with cancer to track and manage their side effects so they can improve… Continue Reading
Talked About